Buy & Sell Boston Beer Company Inc (SAM) – Boston Beer Company Inc Price Today
Key Stats
- $2.00BMarket Cap
- Consumer StaplesSector
- -38.06%3M Drawdown
- $1.87BEnterprise Value
- -Dividend Yield
- 55 daysTypical Hold Time
Boston Beer Company Inc (SAM) is currently valued at a market capitalization of $2.00B, with an enterprise value of $1.87B. Over the past 52 weeks, Boston Beer Company Inc has traded between a low of $161.08 and a high of $260.05, highlighting its annual price range. Over the past three months, Boston Beer Company Inc has recorded a drawdown of -38.06%, reflecting recent price volatility. On average, investors hold Boston Beer Company Inc for approximately 55 days, indicating typical investor behavior on the platform.
About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Most Recent News
Supreme Court rules government geofence data collection is a Fourth Amendment search.
The U.S. Supreme Court ruled in Chatrie v. U.S. that government collection of location data via geofence warrants constitutes a search under the Fourth Amendment. This decision overturns a lower court ruling and requires further review of whether the...
KraneShares China Internet ETF trades near lows amid AI growth and geopolitical risks, rated HOLD.
The KraneShares CSI China Internet ETF (KWEB) provides focused exposure to leading Chinese internet and AI companies and is currently trading near its 52-week lows. The ETF benefits from strong AI-driven growth, government support, and attractive val...
DBV Technologies plans BLA submission for VIASKIN® Peanut patch in kids 4-7 after FDA collaboration.
DBV Technologies is preparing to submit a Biologics License Application (BLA) for its VIASKIN® Peanut patch aimed at children aged 4 to 7 years. The company has engaged in detailed discussions with the FDA to ensure a thorough and efficient review pr...
